Axonal pathology in Japanese Guillain-Barre syndrome: A study of 15 autopsied cases

Neurology

Volumn 48, Issue 6, 1997, Pages 1694-1700

  Sobue, Gen ^a   Li, M ^a   Terao, S ^b   Aoki, S ^a   Ichimura, M ^a   Ieda, T ^a   Doyu, M ^a   Yasuda, T ^a   Hashizume, Y ^b   Mitsuma, T ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFILAMENT PROTEIN;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; MACROPHAGE; MALE; MOTONEURON; MUSCLE ACTION POTENTIAL; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NERVE POTENTIAL; PERIKARYON; PRIORITY JOURNAL; VENTRAL ROOT;

EID: 17444453858     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.6.1694     Document Type: Article

References (28)

1. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine 1969;48:73-215.
2. Honavar M, Tharakan JKJ, Hughes RAC, Leibowitz S, Winer JB. A clinicopathological study of the Guillain-Barré syndrome, nine cases and literature review. Brain 1991;114: 1245-1269.
3. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126.
4. Brown WF, Feasby TE, Hahn AF. Electrophysiological changes in the acute "axonal" form of Guillain-Barré syndrome. Muscle Nerve 1993;16:200-205.
5. Feasby TE, Hahn AF, Brown WB, Bolton CF, Gilbert JJ, Koopman WJ. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 1993;116:185-192.
6. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy, a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342.
7. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China, the spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-595.
8. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China, relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
9. Fuller GN, Jacobs JM, Lewis PD, Lane RJM. Pseudoaxonal Guillain-Barré syndrome: severe demyelination mimicking axonopathy. A case with pupillary involvement. J Neurol Neurosurg Psychiatry 1992;55:1079-1083.
10. Ropper AH, Adelman L. Early Guillain-Barré syndrome without inflammation. Arch Neurol 1992;49:979-981.
11. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal neuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-1902.
12. 1a antibody with severe Guillain-Barré syndrome. Muscle Nerve 1993;16:642-647.
13. Asbury AK, Arnason BGW, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978;3: 565-566.
14. Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A. X-linked recessive bulbospinal neuronopathy: a clinicopathological study. Brain 1989;112:209-232.
15. Sobue G, Yasuda T, Mitsuma T, Pleasure D. Nerve growth factor receptor immunoreactivity in the neuronal perikarya of human sensory and sympathetic nerve ganglia. Neurology 1989;39:937-941.
16. Itoh T, Sobue G, Ken E, Mitsuma T, Takahashi A, Trojanowski JQ. Phosphorylated high molecular weight neurofilament protein in the peripheral motor, sensory and sympathetic neuronal perikarya: system-dependent normal variations and changes in amyotrophic lateral sclerosis and multiple system atrophy. Acta Neuropathol 1992;83:240-245.
17. Terao S, Sobue G, Hashizume Y, Li M, Inagaki T, Mitsuma T. Age-related changes in human spinal ventral horn cells with special reference to the loss of small neurons in the intermediate zone: a quantitative study. Acta Neuropathol 1996;92: 109-114.
18. Campbell B, Novick R. A quantitative method for the study of chromatolysis. Proc Soc Exp Biol Med 1946;61:425-427.
19. Kanda T, Hatashi H, Tanabe H, Tsubaki T, Oda M. A fulminant case of Guillain-Barré syndrome; topographic and fiber size related analysis of demyelinating changes. J Neurol Neurosurg Psychiatry 1989;52:857-864.
20. Kuroki S, Saida T, Nukina M, Haruta T, Yoshioka M, Kobayashi Y. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain b-N-acetylglucosamine residues. Ann Neurol 1993;33:242-247.
21. Rees JH, Gregson NA, Griffiths PL, Hughes RAC. Campylobacter jejuni and Guillain-Barré syndrome. Quart J Med 1993;86:623-634.
22. Van der Meché FGA, Oomes PG, Kleyweg RP, Bänffer JRJ, Meulstee J. Axonal Guillain-Barré syndrome [letter]. Neurology 1991;41:1530.
23. Triggs W, Cros D. Axonal Guillain-Barré syndrome [letter]. Neurology 1993;43:1443.
24. Triggs WJ, Cros D, Gominak SC, et al. Motor nerve inexcitability in Guillain-Barré syndrome, the spectrum of distal conduction block and axonal degeneration. Brain 1992;115:1291-1302.
25. Griffin JW, Li CY, Ho TW, et al. Neuropathology of the "axonal" Guillain-Barré syndrome after Campylobacter jejuni infection. Ann Neurol 1995;118:577-595.
26. Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis. J Neurol Sci 1981;49: 253-271.
27. Itoyama Y, Tateishi J, Kuroiwa Y. Atypical multiple sclerosis with concentric or lamellar demyelinated lesions: two Japanese patients postmortem. Ann Neurol 1985;17:481-487.
28. Ikuta F, Koga M, Takeda S, et al. Comparison of MS pathology between 70 American and 75 Japanese autopsy cases. In: Kuroiwa Y, Kurland LT, eds. Multiple sclerosis east and west. Fukuoka, Japan: Kyushu University Press, 1982:297-306.